Search research articles
Contact Us
Filters
Showing results (261-270 of 536) with videos related to
Page
of 54
Sort By:
Leukemia
|
January 17, 2024
OST-01, a natural product from Baccharis coridifolia, targets c-Myc-dependent ribogenesis in acute myeloid leukemia
HyunJun Kang, Dinh Hoa Hoang, Melissa Valerio, et al.
Blood
|
November 21, 2012
Targeted nanoparticle delivery overcomes off-target immunostimulatory effects of oligonucleotides and improves therapeutic efficacy in chronic lymphocytic leukemia
Bo Yu, Yicheng Mao, Li-Yuan Bai, et al.
Journal of the National Cancer Institute
|
October 15, 2015
Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia
Yu-Chou Tseng, Samuel K Kulp, I-Lu Lai, et al.
Molecular Pharmaceutics
|
February 3, 2009
Transferrin receptor-targeted lipid nanoparticles for delivery of an antisense oligodeoxyribonucleotide against Bcl-2
Xiaojuan Yang, Chee Guan Koh, Shujun Liu, et al.
Blood
|
March 8, 2007
Long-term disease-free survivors with cytogenetically normal acute myeloid leukemia and MLL partial tandem duplication: a Cancer and Leukemia Group B study
Susan P Whitman, Amy S Ruppert, Guido Marcucci, et al.
The AAPS Journal
|
April 19, 2011
Characterization of silvestrol pharmacokinetics in mice using liquid chromatography-tandem mass spectrometry
U V R Vijaya Saradhi, Sneha V Gupta, Ming Chiu, et al.
Bone Marrow Transplantation
|
September 24, 2025
Pulmonary manifestations during neutrophil engraftment in recipients of allogeneic hematopoietic cell transplantation for myelofibrosis
Salman Otoukesh, Idoroenyi Amanam, Dongyun Yang, et al.
Leukemia
|
April 21, 2026
HDAC8 inhibition targets STAT3-MYC axis and synergizes with Venetoclax in KMT2A-rearranged acute myeloid leukemia
Lianjun Zhang, Wancheng Guo, Yu-Hsuan Fu, et al.
Blood
|
May 12, 2026
Targeting PRMT9 Overcomes Venetoclax Resistance in AML by Modulating Splicing and Inhibiting Translation
Yang Li, Xin He, Lei Zhang, et al.
Blood
|
October 18, 2007
FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplications
Susan P Whitman, Amy S Ruppert, Michael D Radmacher, et al.
Page
of 54
Search research articles
Search
Showing results (261-270 of 536) with videos related to
Sort By:
Page
of 54
Leukemia
|
January 17, 2024
OST-01, a natural product from Baccharis coridifolia, targets c-Myc-dependent ribogenesis in acute myeloid leukemia
HyunJun Kang, Dinh Hoa Hoang, Melissa Valerio, et al.
Blood
|
November 21, 2012
Targeted nanoparticle delivery overcomes off-target immunostimulatory effects of oligonucleotides and improves therapeutic efficacy in chronic lymphocytic leukemia
Bo Yu, Yicheng Mao, Li-Yuan Bai, et al.
Journal of the National Cancer Institute
|
October 15, 2015
Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia
Yu-Chou Tseng, Samuel K Kulp, I-Lu Lai, et al.
Molecular Pharmaceutics
|
February 3, 2009
Transferrin receptor-targeted lipid nanoparticles for delivery of an antisense oligodeoxyribonucleotide against Bcl-2
Xiaojuan Yang, Chee Guan Koh, Shujun Liu, et al.
Blood
|
March 8, 2007
Long-term disease-free survivors with cytogenetically normal acute myeloid leukemia and MLL partial tandem duplication: a Cancer and Leukemia Group B study
Susan P Whitman, Amy S Ruppert, Guido Marcucci, et al.
The AAPS Journal
|
April 19, 2011
Characterization of silvestrol pharmacokinetics in mice using liquid chromatography-tandem mass spectrometry
U V R Vijaya Saradhi, Sneha V Gupta, Ming Chiu, et al.
Bone Marrow Transplantation
|
September 24, 2025
Pulmonary manifestations during neutrophil engraftment in recipients of allogeneic hematopoietic cell transplantation for myelofibrosis
Salman Otoukesh, Idoroenyi Amanam, Dongyun Yang, et al.
Leukemia
|
April 21, 2026
HDAC8 inhibition targets STAT3-MYC axis and synergizes with Venetoclax in KMT2A-rearranged acute myeloid leukemia
Lianjun Zhang, Wancheng Guo, Yu-Hsuan Fu, et al.
Blood
|
May 12, 2026
Targeting PRMT9 Overcomes Venetoclax Resistance in AML by Modulating Splicing and Inhibiting Translation
Yang Li, Xin He, Lei Zhang, et al.
Blood
|
October 18, 2007
FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplications
Susan P Whitman, Amy S Ruppert, Michael D Radmacher, et al.
Page
of 54